Accueil   Calls for projects   Call to project Johnson & Johnson Innovation / JLABS

Call to project Johnson & Johnson Innovation / JLABS

Key features of the call for projects

Opening date: June 1st, 2016

Date de clôture : August 31th, 2016

Dimension : International


Thématique(s) médicale(s) : E-health and NTIC, Human health, Medical Technologies, Metabolic diseases, Oncology, Others

Johnson & Johnson Innovation and Janssen Pharmaceuticals, Inc. are bringing together the consumer, medical device and pharmaceutical sectors to award a prize or a series of prizes to the person or team(s) who submits the best idea, technology, or solution that will address a critical health need for the world's population.

Check out the areas of interest, with an emphasis on lung cancer and metabolism.

Solutions will be evaluated based on their ability to meet the following criteria:

  • Address a particular cohort with a critical unmet medical need in Johnson & Johnson’s strategic areas of interest, such as lung cancer and metabolic diseases.
  • Integrate a novel approach that combines pharmaceutical, devices and/or consumer health solutions.
  • Address part or all of the spectrum of prevention, interception and cure.
  • Outline how the award would help them reach a critical milestone within the timeframe of a single year and provide a full “time-to-market” plan for their solution.



The best Ideas, Technologies or Solutions will be awarded with a total grant of  $500,000
(deadline to apply Aug 31, 2016)

Apply here

By continuing your navigation on our site, you accept the use of cookies and the collection of your data and personal information by Lyonbiopôle, for the purposes of measuring the traffic on the website, to provide statistics and to offer you adapted content to your centers of interest. To exercise your rights of access, rectification, opposition, deletion and portability, in accordance with the General Data Protection Regulation (EU 2016/679), you are informed that you can send your request to More details are available by clicking here I agree